AGTR1 and cancer: As it was previously reported that telmisartan can induce cell cycle arrest in G0/G1 [46,47] or G2/M phase [48] depending on the cancer cell line, we next determined whether the novel derivatives retain this ability, even though they do not have the AT1R inhibiting function.